Remove Hospitals Remove Pharmaceutical Manufacturing Remove Specialty Pharmacies
article thumbnail

Join me in May at Asembia’s 2022 Specialty Pharmacy Summit

Drug Channels

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook.

article thumbnail

NOW AVAILABLE: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Is Your Health System’s Potential ROI With An Optimized 340B Program?

Proxsys Rx

ProxsysRx has optimized dozens of 340B programs — generating tens of millions in savings & revenue for the health systems we serve — and the most common question we receive from interested hospitals is, “What’s our 340B network realistically worth?”

article thumbnail

NOW AVAILABLE: The 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

reviews the evolving specialty pharmacy industry and discusses emerging challenges from direct distribution models that bypass wholesale distribution. The notable new material in this 2023-24 edition includes: New data about commercial pricing and reimbursement for provider-administered biosimilars appears in Section 3.2.2.

article thumbnail

Formularies, Formulary Strategies, and Vigilante Formulary Review

Ramblings of a pharmacist

Hospitals and health systems maintain formularies of products that they will stock in the hospital pharmacy and administer to inpatients. Health insurance providers do the same, and usually outsource this function to Pharmacy Benefit Managers. . ” That seems like the more likely scenario here - to quote Dr.